Version 2.78

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
60508-9 Stage/prognostic factors section Set NAACCR v.12
Indent42037-2 Scope of regional lymph node surgery at this facility 98-02 Cancer
Indent39806-5 Summary stage at Dx 2000 revised Cancer
Indent42038-0 Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02 Cancer
Indent39806-5 Summary stage at Dx 2000 revised Cancer
Indent21887-5 SEER summary stage 1977 Cancer
Indent21888-3 Summary stage abbreviated at Dx Cancer
Indent21889-1 Size Tumor mm
Indent21890-9 Extension Cancer
Indent21891-7 Extent of disease Prostate cancer
Indent21892-5 Lymph node involvement Cancer
Indent21893-3 Regional lymph nodes positive [#] Specimen {#}
Indent21894-1 Regional lymph nodes examined [#] Specimen {#}
Indent21895-8 Extent of disease.NAACCR.old 13 digit
Indent21896-6 Extent of disease.NAACCR.old 2 digit
Indent21897-4 Extent of disease.NAACCR.old 4 digit
Indent21898-2 Version used Extent of disease coding system
Indent21917-0 Version used [Identifier] TNM classification
Indent21899-0 Primary tumor.pathology Cancer
Indent21900-6 Regional lymph nodes.pathology [Class] Cancer
Indent21901-4 Distant metastases.pathology [Class] Cancer
Indent21902-2 Stage group.pathology Cancer
Indent21903-0 Descriptor.pathology Cancer Narrative
Indent21904-8 Stager.pathology Cancer
Indent21905-5 Primary tumor.clinical [Class] Cancer
Indent21906-3 Regional lymph nodes.clinical [Class] Cancer
Indent21907-1 Distant metastases.clinical [Class] Cancer
Indent21908-9 Stage group.clinical Cancer
Indent21909-7 Descriptor.clinical Cancer Narrative
Indent21910-5 Stager.clinical Cancer
Indent21921-2 Pediatric stage Cancer
Indent21922-0 Coding system used Cancer pediatric staging
Indent21923-8 Pediatric cancer stager
Indent21924-6 Tumor marker Cancer
Indent59544-7 Lymph-vascular invasion Cancer specimen
Indent42079-4 Tumor size.collaborative staging mm;cm
Indent42080-2 Extension collaborative staging Cancer
Indent42081-0 Collaborative staging tumor size extension evaluation Cancer
Indent42082-8 Collaborative staging lymph nodes Cancer
Indent42083-6 Collaborative staging regional nodes evaluation Cancer
Indent42084-4 Collaborative staging metastasis at diagnosis Cancer
Indent42085-1 Collaborative staging metastasis evaluation Cancer
Indent59475-4 Collaborative staging metastasis at diagnosis - bone involvement Cancer
Indent59476-2 Collaborative staging metastasis at diagnosis - brain involvement Cancer
Indent59477-0 Collaborative staging metastasis at diagnosis - liver involvement Cancer
Indent59478-8 Collaborative staging metastasis at diagnosis - lung involvement Cancer
Indent42086-9 Collaborative staging site-Specific factor 1 Cancer
Indent42087-7 Collaborative staging site-Specific factor 2 Cancer
Indent42088-5 Collaborative staging site-Specific factor 3 Cancer
Indent42089-3 Collaborative staging site-Specific factor 4 Cancer
Indent42090-1 Collaborative staging site-Specific factor 5 Cancer
Indent42091-9 Collaborative staging site-Specific factor 6 Cancer
Indent59489-5 Collaborative staging site-specific factor 7 Cancer
Indent59490-3 Collaborative staging site-specific factor 8 Cancer
Indent59491-1 Collaborative staging site-specific factor 9 Cancer
Indent59492-9 Collaborative staging site-specific factor 10 Cancer
Indent59493-7 Collaborative staging site-specific factor 11 Cancer
Indent59494-5 Collaborative staging site-specific factor 12 Cancer
Indent59495-2 Collaborative staging site-specific factor 13 Cancer
Indent59496-0 Collaborative staging site-specific factor 14 Cancer
Indent59497-8 Collaborative staging site-specific factor 15 Cancer
Indent59498-6 Collaborative staging site-specific factor 16 Cancer
Indent59499-4 Collaborative staging site-specific factor 17 Cancer
Indent59500-9 Collaborative staging site-specific factor 18 Cancer
Indent59501-7 Collaborative staging site-specific factor 19 Cancer
Indent59503-3 Collaborative staging site-specific factor 21 Cancer
Indent59504-1 Collaborative staging site-specific factor 22 Cancer
Indent59505-8 Collaborative staging site-specific factor 23 Cancer
Indent59506-6 Collaborative staging site-specific factor 24 Cancer
Indent59507-4 Collaborative staging site-specific factor 25 Cancer
Indent59488-7 Collaborative staging pre treatment tumor size Cancer
Indent59559-5 Collaborative staging pre treatment extension Cancer
Indent59487-9 Collaborative staging pre treatment tumor size and extension evaluation Cancer
Indent59483-8 Collaborative staging pre treatment lymph nodes Cancer
Indent59486-1 Collaborative staging pre treatment regional nodes evaluation Cancer
Indent59484-6 Collaborative staging pre treatment metastasis at diagnosis Cancer
Indent59482-0 Collaborative staging post treatment tumor size Cancer
Indent59479-6 Collaborative staging post treatment extension Cancer
Indent59480-4 Collaborative staging post treatment lymph nodes Cancer
Indent59481-2 Collaborative staging post treatment metastasis at diagnosis Cancer
Indent42094-3 Derived American Joint Committee on Cancer T Derived
Indent42095-0 Derived American Joint Committee on Cancer T descriptor
Indent42096-8 Derived American Joint Committee on Cancer N
Indent42097-6 Derived American Joint Committee on Cancer N descriptor
Indent42098-4 Derived American Joint Committee on Cancer M
Indent42099-2 Derived American Joint Committee on Cancer M descriptor
Indent42100-8 Derived American Joint Committee on Cancer stage group
Indent59527-2 Derived American Joint Committee on Cancer-7 T
Indent59528-0 Derived American Joint Committee on Cancer-7 T descriptor
Indent59524-9 Derived American Joint Committee on Cancer-7 N
Indent59525-6 Derived American Joint Committee on Cancer-7 N descriptor
Indent59522-3 Derived American Joint Committee on Cancer-7 M
Indent59523-1 Derived American Joint Committee on Cancer-7 M descriptor
Indent59526-4 Derived American Joint Committee on Cancer-7 stage group
Indent59539-7 Derived pre treatment-7 T Cancer
Indent59540-5 Derived pre treatment-7 T descriptor Cancer
Indent59536-3 Derived pre treatment-7 N Cancer
Indent59537-1 Derived pre treatment-7 N descriptor Cancer
Indent59534-8 Derived pre treatment-7 M Cancer
Indent59535-5 Derived pre treatment-7 M descriptor Cancer
Indent59538-9 Derived pre treatment-7 stage group Cancer
Indent59533-0 Derived post treatment-7 T Cancer
Indent59531-4 Derived post treatment-7 N Cancer
Indent59530-6 Derived post treatment-7 M Cancer
Indent59532-2 Derived post treatment-7 stage group Cancer
Indent42101-6 Derived SEER summary stage 1977 Cancer
Indent42102-4 Derived SEER summary stage 2000 Cancer
Indent59529-8 Flag for Derived neoadjuvant therapy not populated Cancer
Indent42103-2 Derived American Joint Committee on Cancer conversion method
Indent42104-0 Derived SEER summary stage 1977 conversion method Cancer
Indent42105-7 Derived SEER summary stage 2000 conversion method Cancer
Indent59508-2 Collaborative staging version.current Cancer
Indent42092-7 Collaborative staging version.first Cancer
Indent42093-5 Collaborative staging version.latest Cancer
Indent42126-3 Comorbidities and complications 1
Indent59858-1 SEER site-specific fact 1 [Identifier] Cancer
Indent59859-9 SEER site-specific fact 2 [Identifier] Cancer
Indent59860-7 SEER site-specific fact 3 [Identifier] Cancer
Indent59861-5 SEER site-specific fact 4 [Identifier] Cancer
Indent59862-3 SEER site-specific fact 5 [Identifier] Cancer
Indent59863-1 SEER site-specific fact 6 [Identifier] Cancer
Indent42116-4 ICD revision comorbidities Cancer
Indent42126-3 Comorbidities and complications 1
Indent42107-3 Comorbidities and complications 2
Indent42108-1 Comorbidities and complications 3
Indent42109-9 Comorbidities and complications 4
Indent42110-7 Comorbidities and complications 5
Indent42111-5 Comorbidities and complications 6
Indent42112-3 Comorbidities and complications 7
Indent42113-1 Comorbidities and complications 8
Indent42114-9 Comorbidities and complications 9
Indent42115-6 Comorbidities and complications 10

Fully-Specified Name

Component
Stage &or prognostic factors section
Property
-
Time
Pt
System
^Patient
Scale
Set
Method
NAACCR v.12

Additional Names

Short Name
Stage/prognost fact section NAACCR v.12

Basic Attributes

Class
TUMRRGT
Type
Clinical
First Released
Version 2.34
Last Updated
Version 2.61
Panel Type
Panel

Member of these Panels

LOINC Long Common Name
59852-4 North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Sección de factores de pronóstico o estadio:-:Punto temporal:^ Paciente:Set:NAACCR v.12
it-IT Italian (Italy) Stadio &o fattori prognostici, sezione:-:Pt:^Paziente:Determinato:NAACCR v.12
Synonyms: Fase paziente Punto nel tempo (episodio) Registro tumori Sezione stadio/fattori prognostici Stabilito;Fissato
zh-CN Chinese (China) 分期和或预后因素小节:-:时间点:^患者:集合型:NAACCR v.12
Synonyms: NAACCR 12 版;NAACCR 版本 12;癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR NAACCR 肿瘤登记;癌症登记中心北美协会肿瘤登记;肿瘤注册;肿瘤登记（NAACCR）;肿瘤登记（癌症登记中心北美协会）;癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR 临床信息附件集;临床信息附件集合;集;集合 分期和或预后因素章节;分期/预后因素小节 分级;阶段;时期 北美癌症登记中心协会 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 时刻;随机;随意;瞬间 癌症登记中心北美协会 癌症登记中心北美协会（North American Association of Central Cancer Registries，NAACCR） 癌症登记中心北美协会;North American Association of Central Cancer Registries;NAACCR

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=60508-9